AU2960789A - Indolocarbazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing them - Google Patents
Indolocarbazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing themInfo
- Publication number
- AU2960789A AU2960789A AU29607/89A AU2960789A AU2960789A AU 2960789 A AU2960789 A AU 2960789A AU 29607/89 A AU29607/89 A AU 29607/89A AU 2960789 A AU2960789 A AU 2960789A AU 2960789 A AU2960789 A AU 2960789A
- Authority
- AU
- Australia
- Prior art keywords
- atoms
- group
- radical
- denote
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Abstract
Novel indolocarbazole derivatives of the general formula I <IMAGE> in which R<1> and R<2> are identical or different and denote hydrogen, a straight-chain or branched alkyl group having 1 to 6 C atoms, a benzyl group, an unsubstituted or substituted aminoalkyl group having up to 12 C atoms, an alkoxycarbonylalkyl radical having up to 6 C atoms, a radical -CH2-CO-NR<3>R<4> in which R<3> and R<4> are identical or different and represent hydrogen, an alkyl group having 1 to 4 C atoms or a benzyl group, or R<1> and/or R<2> denote a haloalkyl, hydroxyalkyl or alkoxyalkyl radical each having up to 6 C atoms, a benzoyloxyalkoxyalkyl, acetyloxyalkoxyalkyl or hydroxyalkoxyalkyl radical each having up to 11 C atoms, or an acyl group having 1 to 4 C atoms or R<1> and R<2> together denote an alkylene group having 2 to 4 C atoms, optionally substituted by hydroxyl, C1-4-alkoxy or amino, X and Y are either identical and in each case both denote hydrogen, or X and Y are different, one of the radicals X or Y representing hydrogen and the other of the two radicals denoting a hydroxyl or an alkoxy group having up to 4 C atoms, with the proviso that not all radicals R<1>, R<2>, X and Y simultaneously denote hydrogen, and their pharmacologically acceptable salts, process for the preparation of the compounds I or of regioisomer mixtures of two of these compounds I and medicines containing at least one of the compounds I.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3803620 | 1988-02-06 | ||
DE3803620A DE3803620A1 (en) | 1988-02-06 | 1988-02-06 | INDOLOCARBAZOL DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THE SAME |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2960789A true AU2960789A (en) | 1989-08-10 |
AU616468B2 AU616468B2 (en) | 1991-10-31 |
Family
ID=6346797
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU29607/89A Ceased AU616468B2 (en) | 1988-02-06 | 1989-02-03 | Indolocarbazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0328000B1 (en) |
JP (1) | JP2866096B2 (en) |
KR (1) | KR890013035A (en) |
CN (1) | CN1035667A (en) |
AT (1) | ATE117304T1 (en) |
AU (1) | AU616468B2 (en) |
CA (1) | CA1337767C (en) |
DD (1) | DD283394A5 (en) |
DE (2) | DE3803620A1 (en) |
DK (1) | DK51489A (en) |
ES (1) | ES2066798T3 (en) |
GR (1) | GR3015194T3 (en) |
HU (1) | HU203758B (en) |
IE (1) | IE65256B1 (en) |
PT (1) | PT89623B (en) |
ZA (1) | ZA89861B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU634247B2 (en) * | 1989-03-23 | 1993-02-18 | Banyu Pharmaceutical Co., Ltd. | Antitumor substance be-13793c |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5618809A (en) * | 1989-12-14 | 1997-04-08 | Schering Corporation | Indolocarbazoles from saccharothrix aerocolonigenes copiosa subsp. nov SCC 1951 ATCC 53856 |
AU7035991A (en) * | 1989-12-14 | 1991-07-18 | Schering Corporation | Indolocarbazoles from saccharothrix aerocolonigenes subsp. copiosa subsp. nov. scc 1951 atcc 53856 |
DE3942296A1 (en) * | 1989-12-21 | 1991-06-27 | Goedecke Ag | INDOLOCARBAZOL DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF |
US5591842A (en) * | 1991-11-29 | 1997-01-07 | Banyu Pharmaceutical Co., Ltd. | Indolopyrrolocarbazole derivatives |
US5668271A (en) * | 1991-11-29 | 1997-09-16 | Banyu Pharmaceutical Co., Ltd. | Indolopyrrolocarbazole derivatives |
WO1993018766A1 (en) * | 1992-03-20 | 1993-09-30 | The Wellcome Foundation Limited | Further indole derivatives with antiviral activity |
DE4243321A1 (en) * | 1992-12-21 | 1994-06-23 | Goedecke Ag | Amino acid derivatives of heterocycles as PKC inhibitors |
US5721230A (en) * | 1993-05-10 | 1998-02-24 | Hoffmann-La Roche Inc. | Substituted pyrroles |
AU678435B2 (en) * | 1993-05-10 | 1997-05-29 | F. Hoffmann-La Roche Ag | Substituted pyrroles |
DE69409641T2 (en) * | 1993-05-28 | 1998-11-26 | Cephalon Inc | APPLICATION OF INDOLOCARBAZOL DERIVATIVES FOR THE TREATMENT OF PROSTATE DISEASES |
US5468872A (en) * | 1993-09-16 | 1995-11-21 | Cephalon, Inc. | K-252a functional derivatives potentiate neurotrophin-3 for the treatment of neurological disorders |
ES2134910T3 (en) * | 1993-12-07 | 1999-10-16 | Lilly Co Eli | SYNTHESIS OF BISINDOLILMALEIMIDAS. |
US5843935A (en) * | 1993-12-07 | 1998-12-01 | Eli Lilly And Company | Protein kinase C inhibitors |
US5541347A (en) * | 1993-12-07 | 1996-07-30 | Eli Lilly And Company | Synthesis of bisindolylmaleimides |
US5723456A (en) * | 1993-12-07 | 1998-03-03 | Eli Lilly & Company | Therapeutic treatment for cardiovascular diseases |
ES2162843T3 (en) * | 1993-12-07 | 2002-01-16 | Lilly Co Eli | INHIBITORS OF PROTEIN QUINASA C. |
US5624949A (en) * | 1993-12-07 | 1997-04-29 | Eli Lilly And Company | Protein kinase C inhibitors |
DK0817627T3 (en) * | 1993-12-23 | 2005-06-06 | Lilly Co Eli | Inhibitors of protein kinase C |
US5804564A (en) * | 1994-05-09 | 1998-09-08 | Banyu Pharmaceutical Co., Ltd. | Antitumor indolopyrrolocarbazole derivatives |
US5922860A (en) * | 1994-05-09 | 1999-07-13 | Banyu Pharmaceutical Co., Ltd. | Antitumor indolopyrrolocarbazole derivatives |
US5491242A (en) * | 1994-06-22 | 1996-02-13 | Eli Lilly And Company | Protein kinase C inhibitors |
US5481003A (en) * | 1994-06-22 | 1996-01-02 | Eli Lilly And Company | Protein kinase C inhibitors |
CA2245029A1 (en) | 1998-03-13 | 1999-09-13 | University Of British Columbia | Granulatimide compounds as g2 checkpoint inhibitors |
WO1999047522A1 (en) * | 1998-03-13 | 1999-09-23 | The University Of British Columbia | Granulatimide derivatives for use in cancer treatment |
US6653290B2 (en) | 2000-10-06 | 2003-11-25 | Bristol-Myers Squibb Company | Tumor proliferation inhibitors |
HUP0400265A2 (en) | 2001-03-22 | 2004-08-30 | Bristol-Myers Squibb Co. | Topoisomerase i selective cytotoxic sugar derivatives of indolopyrrolocarbazoles and their use for preparation of pharmaceutical compositions |
CA2393720C (en) | 2002-07-12 | 2010-09-14 | Eli Lilly And Company | Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride |
CN117486782A (en) * | 2023-12-29 | 2024-02-02 | 中国医学科学院药用植物研究所 | N-substituted carbazole derivative and preparation method and application thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62155284A (en) * | 1985-12-27 | 1987-07-10 | Kyowa Hakko Kogyo Co Ltd | Physiologically active substance k-252 derivative |
US4737496A (en) * | 1986-10-01 | 1988-04-12 | Ciba-Geigy Corporation | 1,3,4,16b-tetrahydro-2H,10H-indolo[2,1-c]pyrazino-[1,2-a][1,4]benzodiazepines useful as serotonin-2 receptor antagonists |
-
1988
- 1988-02-06 DE DE3803620A patent/DE3803620A1/en not_active Withdrawn
-
1989
- 1989-02-03 HU HU89548A patent/HU203758B/en not_active IP Right Cessation
- 1989-02-03 ES ES89101940T patent/ES2066798T3/en not_active Expired - Lifetime
- 1989-02-03 EP EP89101940A patent/EP0328000B1/en not_active Expired - Lifetime
- 1989-02-03 CA CA000590001A patent/CA1337767C/en not_active Expired - Fee Related
- 1989-02-03 DE DE58908892T patent/DE58908892D1/en not_active Expired - Fee Related
- 1989-02-03 IE IE35989A patent/IE65256B1/en not_active IP Right Cessation
- 1989-02-03 ZA ZA89861A patent/ZA89861B/en unknown
- 1989-02-03 DK DK051489A patent/DK51489A/en not_active Application Discontinuation
- 1989-02-03 PT PT89623A patent/PT89623B/en not_active IP Right Cessation
- 1989-02-03 DD DD89325511A patent/DD283394A5/en not_active IP Right Cessation
- 1989-02-03 AU AU29607/89A patent/AU616468B2/en not_active Ceased
- 1989-02-03 AT AT89101940T patent/ATE117304T1/en not_active IP Right Cessation
- 1989-02-04 CN CN89100641A patent/CN1035667A/en active Pending
- 1989-02-04 KR KR1019890001349A patent/KR890013035A/en not_active Application Discontinuation
- 1989-02-06 JP JP1027350A patent/JP2866096B2/en not_active Expired - Fee Related
-
1995
- 1995-02-27 GR GR950400404T patent/GR3015194T3/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU634247B2 (en) * | 1989-03-23 | 1993-02-18 | Banyu Pharmaceutical Co., Ltd. | Antitumor substance be-13793c |
Also Published As
Publication number | Publication date |
---|---|
EP0328000A3 (en) | 1991-04-03 |
AU616468B2 (en) | 1991-10-31 |
HU203758B (en) | 1991-09-30 |
ES2066798T3 (en) | 1995-03-16 |
JPH02149520A (en) | 1990-06-08 |
ZA89861B (en) | 1989-11-29 |
PT89623B (en) | 1994-02-28 |
KR890013035A (en) | 1989-09-21 |
CN1035667A (en) | 1989-09-20 |
EP0328000B1 (en) | 1995-01-18 |
PT89623A (en) | 1989-10-04 |
DD283394A5 (en) | 1990-10-10 |
JP2866096B2 (en) | 1999-03-08 |
IE65256B1 (en) | 1995-10-18 |
DK51489D0 (en) | 1989-02-03 |
DE3803620A1 (en) | 1989-08-17 |
ATE117304T1 (en) | 1995-02-15 |
DK51489A (en) | 1989-08-07 |
GR3015194T3 (en) | 1995-05-31 |
IE890359L (en) | 1989-08-06 |
CA1337767C (en) | 1995-12-19 |
EP0328000A2 (en) | 1989-08-16 |
DE58908892D1 (en) | 1995-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2960789A (en) | Indolocarbazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing them | |
IL107426A (en) | 3-HALO-8-ARALKOXY (OR ARALKYLAMINO) IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
GB8919417D0 (en) | Novel compounds | |
EP0163599A3 (en) | Pyrimidopyrimidine derivatives, processes for producing them, pharmaceutical compositions containing them and their use as anti-allergic agents | |
IL102354A (en) | Pharmaceutically active hydrazine derivatives and process for the preparation thereof | |
AR033996A1 (en) | A 7-OXO-PYRIDOPIRIMIDINE, ITS USE, A PROCESS TO PREPARE IT, A PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, A PROCESS TO PRODUCE A PYRIMIDINE, A PROCESS TO PRODUCE A PYRIDOPIRIMIDINE, AND PREPARED COMPOUNDS THROUGH | |
NZ214787A (en) | Arylcyclobutylalkylamines and pharmaceutical compositions | |
ATE40358T1 (en) | 2,3-DIHYDROBENZOFURAN DERIVATIVES, SEVERAL PROCESSES FOR THEIR PRODUCTION AND PHARMACEUTICALS CONTAINING THEM. | |
DK96783D0 (en) | PROCEDURE FOR PREPARING 4 '' - EPIERYTHROMYCINE A OR DERIVATIVES THEREOF | |
HUT50142A (en) | Process for producing allyl-mercapto-acetyl-sidnonimine derivatives and pharmaceutical compositions containing them | |
IE901314L (en) | 2- substituted-n,n'-di(trimethoxybenzoyl)piperazines | |
IL106356A (en) | 4-amino-n-(4-methyl- 4-piperidinyl)- 2-methoxybenzamides, their preparation and pharmaceutical compositions containing them | |
DE69029781T2 (en) | Anthracycline glycoside derivatives and process for their preparation | |
DE3161553D1 (en) | Thiazolo(3,2-a)pyrimidine derivatives, their preparation and pharmaceutical compositions containing them | |
FR2630111B1 (en) | NOVEL TRIENIC DERIVATIVES WITH CHROMENIC STRUCTURE, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
ZA934110B (en) | Diacylglycerol nicotinates, process fot their preparation and the pharmaceutical compositions which contain them | |
HUT45059A (en) | Process for producing abeoergoline derivatives | |
SE9203824L (en) | BENSOFURANYLIMIDAZOLE DERIVATIVES, PROCEDURES FOR PREPARING THEREOF AND THERAPEUTIC COMPOSITIONS CONTAINING THEM | |
ATE36154T1 (en) | 4-PHENYLAMINOPYRIDIN DERIVATIVES, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICALS CONTAINING THEM. | |
ES2006336A6 (en) | 2,3-Dihydro-3-phenyl-benzofuran-2-one acetamide derivatives, processes for their preparation and pharmaceutical compositions containing them. | |
ES8605819A1 (en) | Antiviral nucleoside derivatives | |
KR890009916A (en) | Rapdan derivatives, methods for their preparation and use as medicaments thereof |